Author Correction: NRF2-GPX4/SOD2 axis imparts resistance to EGFR-tyrosine kinase inhibitors in non-small-cell lung cancer cells.

Ma, Chun-Shuang; Lv, Qian-Ming; Zhang, Ke-Ren; Tang, Ya-Bin; Zhang, Yu-Fei; Shen, Ying; Lei, Hui-Min; Zhu, Liang

Ma, Chun-Shuang; Lv, Qian-Ming; Zhang, Ke-Ren; Tang, Ya-Bin; Zhang, Yu-Fei; Shen, Ying; Lei, Hui-Min; Zhu, Liang.

Afiliación

Ma CS; Department of Pharmacology and Chemical Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Lv QM; Department of Pharmacology and Chemical Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Zhang KR; Department of Pharmacology and Chemical Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Tang YB; Department of Pharmacology and Chemical Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Zhang YF; Shanghai Collaborative Innovation Center for Translational Medicine, Shanghai, 200025, China.
Shen Y; Department of Pharmacology and Chemical Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Lei HM; Department of Pharmacology and Chemical Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. yshen0510@sjtu.edu.cn.
Zhu L; Shanghai Collaborative Innovation Center for Translational Medicine, Shanghai, 200025, China. yshen0510@sjtu.edu.cn.

Acta Pharmacol Sin ; 44(11): 2346, 2023 Nov.

Article en En | MEDLINE | ID: mdl-37528234

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Acta Pharmacol Sin Asunto de la revista: FARMACOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google